Fig. 1.

Five-year survival for patients with pancreatic ductal adenocarcinoma diagnosed with localized, regional (i.e. lymph node involvement), or distant (i.e. metastatic to other organs) disease. Graph is based on mortality data from the National Center for Health Statistics reported for 2006 [90], 2012 [91], and 2019 [1] by the American Cancer Society. Numbers associated with histogram bars indicate percent of patients alive at ≥5 years after diagnosis.